Is patient's age a prognostic factor for follicular thyroid carcinoma in the TNM classification system?

Thyroid

Volumn 15, Issue 5, 2005, Pages 439-448

  Besic, Nikola ^a   Zgajnar, Janez ^a   Hocevar, Marko ^a   Frkovic Grazio, Snjezana ^a  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER SURVIVAL; CANCER THERAPY; DISEASE COURSE; FEMALE; FOLLOW UP; GENDER; HUMAN; HURTHLE CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID PARAFOLLICULAR CELL; TUMOR VOLUME;

ADENOMA, OXYPHILIC; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; CARCINOMA, PAPILLARY, FOLLICULAR; CHILD; FEMALE; HUMANS; IODINE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROGNOSIS; SLOVENIA; SODIUM CHLORIDE, DIETARY; SURVIVAL ANALYSIS; THYROID NEOPLASMS;

EID: 20044369228     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2005.15.439     Document Type: Article

References (58)

1. Hannequin P, Liehn JC, Delisle MJ 1986 Multifactorial analysis of survival in thyroid cancer. Pitfalls of applying the results of published studies to another population. Cancer 58:1749-1755.
2. Shaha AR, Loree TR, Shah JP 1995 Prognostic factors and risk group analysis in follicular carcinoma of the thyroid. Surgery 118:1131-1138.
3. Mueller-Gaertner HW, Tomic-Brzac H, Rehpenning W 1991 Prognostic indices for tumor relapse and tumor mortality in follicular thyroid carcinoma. Cancer 67:1903-1911.
4. Grebe SKG, Hay ID 1995 Follicular thyroid cancer. Endocrinol Metabol Clin North Am 4:761-801.
5. Brennan MD, Bergstralh EJ, Heerden JA, McConahey WM 1991 Follicular thyroid cancer treated at the Mayo clinic, 1946 through 1970: Initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc 66: 11-22.
6. Böttger T, Klupp J, Sorger K, Junginger T 1990 Prognostisch relevante Faktoren beim follikularen Schilddrusenkarzinom. Langenbecks Arch Chir 375:266-271.
7. Byar DP, Green SB, Dor P, Williams D, Colon J, van Gilse HA, Mayer M, Sylvester RJ, van Glabbeke M 1979 A prognostic index for thyroid carcinoma. A study of the EORTC thyroid cancer cooperative group. Eur J Cancer 15: 1033-1041.
8. Casara D, Rubello D, Saladini G, Masarotto, Favero A, Girelli ME, Busnardo B 1993 Different features of pulmonary metastases in differentiated thyroid cancer: Natural history and multivariate statistical analysis of prognostic variables. J Nucl Med 34:1626-1631.
9. Goldman ND, Coniglio JU, Falk SA 1996 Thyroid Cancers I. Papillary, follicular, and Hürthle cell. Otorinol Clin North Am 4:593-609.
10. Hamming JF, Van de Velde CJH, Goslings BM, Schelfhout LJDM, Fleuren GJ, Hermans J, Zwaveling A 1989 Prognosis and morbidity after total thyroidectomy for papillary, follicular and medullary thyroid cancer. Eur J Cancer Clin Oncol 25:1317-1323.
11. Hay ID, Rock MG, Sim FH, Swee RG, Unni KK, Gundrerson LL 1988 Thyroid cancer. In: Sim FH (ed) Diagnosis and Management of Metastatic Bone Disease. A Multidisciplinary Approach. Raven Press, New York, pp. 305-317.
12. Herrera MF, Hay ID, Wu PS, Goellner JR, Ryan JJ, Ebersold JR, Berstralh EJ, Grant CS 1992 Hürthle cell (oxyphilic) papillary thyroid carcinoma: A variant with more aggressive biologic behavior. World J Surg 16:669-675.
13. Kerr DJ, Burt AD, Boyle P, MacFarlane GJ, Storer AM, Brewin TB 1986 Prognostic factors in thyroid tumors. Br J Cancer 54:475-182.
14. Lang W, Chortz H, Hundeshagen H 1986 Risk factors in follicular thyroid carcinomas. A retrospective follow-up study covering a 14-year period with emphasis on morphological findings. Am J Surg Pathol 10:246-255.
15. Ruegemer JJ, Hay ID, Bergstralh EJ, Ryan JJ, Offord KP, Gorman CA 1988 Distant metastases in differentiated thyroid carcinoma: A multivariate analysis of prognostic variables. J Clin Endocr Metabol 67:501-508.
16. Schelfhout LJ, Creutzberg CL, Hamming JF, Fleuren GJ, Smeenk D, Hermans J, van de Velde CJ, Goslings BM 1988 Multivariate analysis of survival in differentiated thyroid cancer: The prognostic significance of the age factor. Eur J Cancer Clin Oncol 24:331-337.
17. Simpson WJ, McKinney SE, Carruthers JS, Gospodarowicz MK, Sutcliffe SB, Panzarella T 1987 Papillary and follicular thyroid cancer. Prognostic factors in 1578 patients. Am J Med 83:479-188.
18. Simpson WJ, Panzarella T, Carruthers JS, Gospodarowicz MK, Sutcliffe SB 1988 Papillary and follicular thyroid cancer: Impact of treatment in 1578 patients. Int J Radiation Oncol Biol Phys 14:1063-1075.
19. Staunton MD, Bourne H 1992 Malignant thyroid tumours 1932 to 1972: The outcome in 492 patients. Eur J Surg Oncol 18:469-474.
20. Tennvall J, Biorklund A, Moller T, Ranstam J, Akerman M 1985 Prognostic factors of papillary, follicular and medullary carcinomas of the thyroid gland. Retrospective multivariate analysis of 216 patients with a median follow-up of 11 years. Acta Radiol Oncol 24:17-24.
21. Tubiana M, Schlumberger M, Rougier P, Laplanche A, Benhamou E, Gardet P, Caillou B, Travagli JP, Parmentier C 1985 Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 55:794-804.
22. Van Heerden JA, Hay ID, Goellner JR, Salomao D, Ebersold JR, Bergstralh EJ, Grant CS 1992 Follicular thyroid carcinoma with capsular invasion alone: A nonthreatening malignancy. Surgery 112:1130-1138.
23. Segal K, Arad A, Lubin E, Shpitzer T, Hadar T, Feinmesser R 1994 Follicular carcinoma of the thyroid. Head Neck 16:533-538.
24. Szanto J, Ringwald G, Karika Z, Liszka G, Peter I, Daubner K 1991 Follicular cancer of the thyroid gland. Oncology 48:483-489.
25. Schröder S, Baisch H, Rehpenning, Müller-Gärtner HW, Schulz-Bischof K, Sablotny B, Meiners I, Bocker W, Schreiber HW 1987 Morphologie und Prognose des folliculären Schilddrüsencarcinoms-Eine klinisch-pathologische und DNS-cytometrische Untersuchung an 95 Tumoren. Langenbecks Arch Chir 370:3-24.
26. Carcangiu ML, Bianchi S, Savino D, Voynick IM, Rosai J 1991 Follicular Hürthle cell tumors of the thyroid gland. Cancer 68:1944-1953.
27. Joensuu H, Klemi PJ, Paul R, Tuominen J 1986 Survival and prognostic factors in thyroid carcinoma. Acta Radiol Oncol 25:243-248.
28. Grant CS, Hay ID, Ryan JJ, Bergstrahl EJ, Rainwater LM, Goellner JR 1990 Diagnostic and prognostic utility of flow cytometric DNA measurements in follicular thyroid tumors. World J Surg 14:283-290.
29. Samaan NA, Schultz PN, Hickey RC, Goepfert H, Haynie TP, Johnston DA, Ordonez NG 1992 The results of various modalities of treatment of well differentiated thyroid carcinomas: A retrospective review of 1599 patients. J Clin Endocrinol Metab 75:714-720.
30. Brierley JD, Panzarella T, Tsang RW, Gospodarowicz MK, O'Sullivan B 1997 A comparison of different staging systems predictability of patient outcome. Thyroid carcinoma as an example. Cancer 79:2414-2423.
31. Passler C, Prager G, Scheuba C, Kaserer K, Zettinig G, Niederle B 2003 Application of staging systems for differentiated thyroid carcinoma in an endemic goiter region with iodine substitution. Ann Surg 237:227-234.
32. Tsang RW, Brierley JD, Simpson WJ, Panzarella T, Gospodarowicz MK, Sutcliffe SB 1998 The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Cancer 82:375-388.
33. Sanders LE, Silverman M 1998 Follicular and Hürthle cell carcinoma: Predicting outcome and directing therapy. Surgery 124:967-974.
34. Chow SM, Law SC, Mendenhall WM, Au SK, Yau S, Yuen KT, Law CC, Lau WH 2002 Follicular thyroid carcinoma: prognostic factors and the role of radioiodine. Cancer 95:488-498.
35. Bhattacharyya N. 2003 Survival and prognosis in Hürthle cell carcinoma of the thyroid gland Arch Otolaryngol Head Neck Surg 129:207-210.
36. Lopez-Penabad L, Chiu AC, Hoff AO, Schultz P, Gaztambide S, Ordonez NG, Sherman SI 2003 Prognostic factors in patients with Hürthle cell neoplasms of the thyroid. Cancer 97:1186-1194.
37. Besic N, Auersperg M, Golouh R 1999 Prognostic factors in follicular carcinoma of the thyroid - a multivariate survival analysis. Eur J Surg Oncol 25:599-605.
38. Cady B, Rossi R 1988 An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 104:947-953.
39. Hay ID, Grant CS, Taylor WF, McConahey WM 1987 Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: A retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 102:1088-1095.
40. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS 1993 Predicting outcome in papillary thyroid carcinoma: Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114: 1050-1057.
41. Sherman SI, Brierley JD, Sperling M, Ain KB, Bigos ST, Cooper DS, Haugen BR, Ho M, Klein I, Ladenson PW, Robbins J, Ross DS, Specker B, Taylor T, Maxon HR 3rd 1998 Prospective multicenter study of thyroid carcinoma treatment: Initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer 83:1012-1021.
42. Sobin LH, Wittekind Ch 2002 TNM Classification of Malignant Tumours, 6th ed. UICC. Wiley-Liss, New York, pp. 52-56.
43. Jean Me, Termuhlen PM, Grau AM 2003 Carcinoma of the thyroid and parathyroid glands. In: Feig BW, Berger DH, Fuhrman GM (eds) The MD Anderson Surgical Oncology Handbook. Lippincott Williams & Wilkins, Philadelphia, pp. 370-392.
44. Gaberscek S, Krhlin B, Hojker S 2004 Precej manj povecanih scitnic: preskrba slovenske populacije z jodom se je pomembno izboljsala. Delo 46:9.
45. Galera-Davidson H, Gonzales-Campora R 1997 Thyroid. In: Bibbo M (ed) Comprehensive Cytopathology, 2nd ed. WB Saunders Company, Philadelphia, pp. 673-701.
46. Orell SR, Philips J 1997 Cytological patterns in thyroid disease diagnosis and differential diagnosis in fine needle biopsy smears. In: Orell SR, Philips J (eds) The Thyroid. Karger, Basel, pp. 61-185.
47. Akslen LA 1993 Prognostic importance of histologic grading in papillary thyroid carcinoma. Cancer 72:2680-2685.
48. Auersperg M, Us-Krasovec M, Petric G, Pogacnik A, Besic N 1990 Results of combined modality treatment in poorly differenatiated and anaplastic thyroid carcinoma. Wien Klin Wochenschr 102:267-270.
49. Kaplan EL, Meier P 1985 Non-parametric estimation from incomplete observations. J Am Stat Assoc 53:457-481.
50. Mantel N 1966 Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170.
51. Cox DR 1972 Regression models and life-tables (with discussion). J R Statist Soc (B) 34:187-220.
52. Grebe SK, Hay ID 1995 Follicular thyroid cancer. Endocrinol Metab Clin North Am 24:761-801.
53. Hermanek P, Sobin LH 1992 TNM Classification of Malignant Tumours. UICC. Springer-Verlag, Berlin, pp. 35-37.
54. Lind P, Kumnig G, Heinisch M, Igerc I, Mikosch P, Gallowitsch HJ, Kresnik E, Gomez I, Unterweger O, Aigner H 2002 Iodine supplementation in Austria: Methods and results. Thyroid 12:903-907.
55. Gomez Segovia I, Gallowitsch HJ, Kresnik E, Kumnig G, Igerc I, Matschnig S, Stronegger WJ, Lind P 2004 Descriptive epidemiology of thyroid carcinoma in Carinthia, Austria: 1984-2001. Histopathologic features and tumor classification of 734 cases under elevated general iodination of table salt since 1990: Population-based age-stratified analysis on thyroid carcinoma incidence. Thyroid 14: 277-286.
56. Lind P, Langsteger W, Molnar M, Gallowitsch HJ, Mikosch P, Gomez I 1998 Epidemiology of thyroid diseases in iodine sufficiency. Thyroid 8:1179-1183.
57. Cooper DS, Schneyer CR 1990 Follicular and Hürthle cell carcinoma of the thyroid. Endocrinol Metab Clin North Am 19:577-591.
58. Tennvall J, Biorklund A, Moller T, Ranstam J, Akerman M 1986 Is the EORTC prognostic index of thyroid cancer valid in differentiated thyroid carcinoma? Retrospective multivariate analysis of differentiated thyroid carcinoma with long follow-up. Cancer 57:1405-1414.